Background/Aims: JX-594 is an oncolytic virus derived from the Wyeth vaccinia strain that causes replication-dependent cytolysis and antitumor immunity. Starting with a cross-examination of clinical-trial samples from advanced hepatocellular carcinoma patients having high levels of aldosterone and virus amplification in JX-594 treatment, we investigated the association between virus amplification and aldosterone in human cancer cell lines. Methods: Cell proliferation was determined by a cell-counting-kit-based colorimetric assay, and vaccinia virus quantitation was performed by quantitative polymerase chain reaction (qPCR) and a viral plaque assay. Also, the intracellular pH was measured using a pH-sensitive dye. Results: Simultaneous treatment with JX-594 and aldosterone significantly increased viral replication in A2780, PC-3, and HepG2 cell lines, but not in U2OS cell lines. Furthermore, the aldosterone treatment time altered the JX-594 replication according to the cell line. The JX-594 replication peaked after 48 and 24 hours of treatment in PC-3 and HepG2 cells, respectively. qPCR showed that JX-594 entry across the plasma membrane was increased, however, the changes are not significant by the treatment. This was inhibited by treatment with spironolactone (an aldosterone-receptor inhibitor). JX-594 entry was significantly decreased by treatment with EIPA [5-(N-ethyl-N-isopropyl)amiloride; a Na 
MATERIALS AND METHODS

Chemicals
Aldosterone, spirinolactone and 5-(N-Ethyl-N-isopropyl) amiloride (EIPA) were purchased from Sigma Aldrich. 2-, 7-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein acetoxymethyl ester (BCECF-AM) from Molecular Probe (Eugene, Ore., USA).
Viruses and cell lines
JX-594 was constructed from a Wyeth strain vaccinia virus (vv) as described, 5 and JX-963 was constructed from a Western Reserve vaccinia virus as described. 6 Both wild type Wyeth strain vv and WR strain vv were purchased from ATCC. Human hepatocellular carcinoma cell lines (SNU-449 and SNU-475)
were obtained from Korea Cell Bank (Seoul, Korea) and all other cell lines used were obtained from ATCC.
Measurement of cell viability
Cell Counting Kit-8 (CCK-8, Dojindo Molecular Technologies, Inc., Japan) was used in accordance with a company provided manual to determine cell growth. In brief, the cells were plated in 
Measurement of plasma membrane influx of vaccinia virus
As vv replication was highest in PC-3 cell line after 48 hours incubation, qPCR quantitation in PC-3 cell line was used to determine vv influx. (1 μM) which were diluted in serum free media. This patient was enrolled into JX-594 Phase 1 hepatoma trial. 
Statistical analysis
Values are given as mean ± SD (standard deviation). Statistical evaluations of data were analyzed using student t test. P-value of less than 0.05 was defined as statistically significant.
RESULTS
Among patients with significant malignant ascites who were enrolled into phase 1 trial, 3 archival serum (supine position) was available in one patient (#303 patient) to measure aldosterone/ cortisol level (Table 1) . Cortisol level was stable roughly within the normal range (5-25 μg/dL), but aldosterone level was maintained at around 10 folds higher than the normal range Thus, direct effect of aldosterone on JX-594 amplification in human cell lines were determined (Fig. 1) . As A2780 cancer cell line has been used for viral titering during Phase 1 and Phase 2 JX-594 study, A2780 cell line was initially chosen to determine the aldosterone effect on JX-594 amplification. Simultaneous treatment of JX-594 and aldosterone (10 nM) significantly increased viral replication in A2780 (human ovarian cancer cell line), which was completely blocked by co-treatment with MR inhibitor, spirinolactone (Fig. 1A) . However, treatment of cortisol alone did not affect viral replication (data not shown). As aldosterone effect may be induced on both genomic and/or nongenomic level, 9 we determined whether pretreatment time of aldosterone (10 nM) could influence viral replication (Fig. 1B) .
While there was significant increase in JX-594 replication after 0 (simultaneous treatment) to 6 hours pre-treatment of aldosterone, further increase after 8 or 10 hour treatment was observed.
Subsequently, it was determined whether the stimulation of JX-594 amplification by aldosterone (10 nM) can vary depending on human cancer cell lines. Fig. 1C shows that there were minor to major differences in JX-594 replications depending on cell types. PC-3 cell showed the highest JX-594 replication after 48
hour treatment but HepG2 cell showed its peak replication after 24 hour treatment. Even with different patterns of aldosterone effect in different cell lines, the overall stimulatory effect of aldosterone in JX-594 amplification in PC3 cell and HepG2 cells but not in U2OS cell was observed.
As aldosterone has been reported to proliferate some types of cells such as heart cell, 10 peripheral blood monocytes 11 or human uterine leiomyoma, 12 it was determined that the stimulation of JX-594 amplification may be via cell proliferation by aldosterone. As vaccinia virus enters cell in an extracellular H + dependent fashion 7, 13 and aldosterone can cause a change in cytosolic pH in specific cell lines, 14, 15 we addressed the possibility that change in hydrogen gradient across the plasma membrane can be involved in stimulation of JX-594 amplification in this study. For this purpose, we developed an assay for JX-594 entry into plasma membrane (Fig. 2) . In this assay, qPCR based quantification of JX-594 entry after its treatment into cultured cells showed linearity plot of Ct and treated viral doses of 1-0.01 MOI ( Fig. 2A) . JX-594 copy number was stable until 2 hours post treatment, but significant increase at 4 hour post JX-594 treatment suggesting no viral replication at least for 2 hours post JX-594 treatment (Fig. 2B) . Therefore we chose the condition of 30 minutes treatment after administration of 1 MOI JX-594 to measure viral entry but not replication. Quality controlled qPCR assay for clinical samples 3 was used in this study. infection. We speculate non-genomic level to be involved in aldosterone as well, and this can be seen in transient treatment of aldosterone affecting pH and virus entry (Fig. 3) . Overall, the results of this study show that aldosterone can increase vaccinia virus entrance in vitro which may be responsible for increased viral amplification. The reason for minimum increase of viral entry by aldosterone determined by qPCR in this study (Fig. 3) may be due to technical limitations (qPCR after 30 minutes treatment at 4℃ to exclude the possibility of JX-594 replication step). Previous studies showed that extracellular acidity can affect vaccinia virus mobility 16 and acidic solution can stimulate vaccinia virus entrance into host cell. 7, 13 In this study, In other aspect, vaccinia virus as a smallpox vaccination in human is being considered with the emergence of bioterrorism. 19 However, post vaccination encephalitis was reported to be a serious safety concern for future vaccination 20 . Therefore, as is 
